Drug:
Reaction: ILLNESS
20250101 - 20251231
No. 1 - 100
No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
1 | 25138822 |
PT |
48 | |
Off label use, Drug dose omission by device, Oxygen saturation decreased, Illness, Device delivery system issue, |
||||
2 | 25138880 |
US |
||
Pulmonary embolism, Illness, Lung disorder, Abdominal pain, Feeling abnormal, |
||||
RISANKIZUMAB-RZAA, |
||||
3 | 25138913 |
US |
||
Illness, |
||||
TIRZEPATIDE, |
||||
4 | 25138951 |
US |
2 | |
Illness, |
||||
ALEMTUZUMAB, |
||||
5 | 25138981 |
CA |
68 | 2 |
Illness, Intra-abdominal fluid collection, Blood pressure increased, Decreased appetite, Nasopharyngitis, Aspartate aminotransferase abnormal, Blood alkaline phosphatase abnormal, Abdominal discomfort, Pruritus, Product dose omission issue, Product use issue, |
||||
OBETICHOLIC ACID, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE, METOPROLOL, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, DULOXETINE HYDROCHLORIDE, DULOXETINE HYDROCHLORIDE, DULOXETINE HYDROCHLORIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, VITAMIN C, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, |
||||
6 | 25138998 |
US |
||
Pneumonia bacterial, Illness, Product dose omission issue, |
||||
7 | 25139210 |
US |
||
Illness, |
||||
EVOLOCUMAB, |
||||
8 | 25139328 |
US |
2 | |
Illness, |
||||
AMBRISENTAN, TREPROSTINIL, RIOCIGUAT, WARFARIN, |
||||
9 | 25139347 |
US |
||
Illness, |
||||
TIRZEPATIDE, |
||||
10 | 25139410 |
US |
||
Illness, Product dose omission issue, Musculoskeletal disorder, Device leakage, Muscular weakness, |
||||
BENRALIZUMAB, |
||||
11 | 25139659 |
US |
2 | |
Delirium, Dyspepsia, Illness, |
||||
TERBINAFINE HYDROCHLORIDE, TERBINAFINE TABLETS 250 MG, TERBINAFINE HYDROCHLORIDE 1G IN 100G, |
||||
12 | 25139702 |
GB |
32 | |
Type 2 diabetes mellitus, Myocardial infarction, Impaired gastric emptying, Nerve injury, Eye swelling, Eye haemorrhage, Visual impairment, Illness, Dysstasia, Gait disturbance, Disturbance in attention, Sleep disorder, Diarrhoea, Vomiting, Depressed mood, Suicidal ideation, Anxiety, Eating disorder, |
||||
OLANZAPINE, |
||||
13 | 25139857 |
US |
||
Illness, |
||||
BELIMUMAB, BELIMUMAB, |
||||
14 | 25139917 |
US |
62 | 2 |
Cough, Illness, |
||||
LENALIDOMIDE, |
||||
15 | 25140012 |
US |
2 | |
Illness, Product dose omission issue, |
||||
BELIMUMAB, |
||||
16 | 25140074 |
US |
70 | 2 |
Chemotherapy, Illness, Feeding disorder, Inappropriate schedule of product administration, |
||||
PANCRELIPASE, |
||||
17 | 25140158 |
US |
87 | |
Asthma, Pulmonary hypertension, Meningitis aseptic, Chronic lymphocytic leukaemia, COVID-19, Cardiac failure, Confusional state, Adrenal insufficiency, Oxygen saturation abnormal, Dyspnoea, Lymphoedema, Diastolic dysfunction, Hypersensitivity, Snoring, Insomnia, Dyspnoea exertional, Upper-airway cough syndrome, Productive cough, Cough, Wheezing, Fatigue, Nasopharyngitis, Leukocytosis, Lymphocytosis, Pulmonary mass, Oesophageal disorder, Chest discomfort, Device malfunction, Poor quality sleep, Somnolence, Device use issue, Illness, Hypertension, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, MONTELUKAST, FLUTICASONE PROPIONATE, TRIPROLIDINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, OBINUTUZUMAB, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, FUROSEMIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, AZELASTINE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, CARVEDILOL, VALACYCLOVIR HYDROCHLORIDE, ERGOCALCIFEROL, METHYLPREDNISOLONE SODIUM SUCCINATE, |
||||
18 | 25140252 |
US |
50 | 1 |
Small intestinal obstruction, Sepsis, Hypotension, Illness, Gallbladder disorder, Infection, Pyrexia, Infection, Fungal infection, |
||||
RIOCIGUAT, RIOCIGUAT, RIOCIGUAT, TREPROSTINIL, TREPROSTINIL, AMBRISENTAN, TREPROSTINIL, NITRIC OXIDE, AMBRISENTAN, |
||||
19 | 25140548 |
US |
2 | |
Illness, Vomiting, |
||||
CARIPRAZINE, |
||||
20 | 25140666 |
US |
45 | 1 |
Fall, Coma, Blood glucose decreased, Loss of consciousness, Blood glucose increased, Impaired gastric emptying, Illness, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
21 | 25140667 |
GB |
58 | 2 |
Illness, Vomiting, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
22 | 25141015 |
US |
69 | 2 |
Derealisation, Poisoning, General physical health deterioration, Movement disorder, Illness, Visual impairment, Gait disturbance, Pain, Crying, Burning sensation, Hepatic enzyme abnormal, Suspected counterfeit product, Expired product administered, Product use in unapproved indication, |
||||
TINIDAZOLE, |
||||
23 | 25141026 |
US |
||
Illness, Fatigue, Muscle tightness, Paraesthesia, |
||||
UBLITUXIMAB, UBLITUXIMAB, |
||||
24 | 25141189 |
US |
1 | |
Illness, |
||||
NATALIZUMAB, |
||||
25 | 25141339 |
US |
1 | |
Illness, |
||||
FOSTAMATINIB, FOSTAMATINIB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, CHOLESTYRAMINE, LORATADINE, LORATADINE TABLET, DESONIDE, SACUBITRIL AND VALSARTAN, FAMOTIDINE, FLUTICASONE PROPIONATE, TRIPROLIDINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, EMPAGLIFLOZIN, ESCITALOPRAM, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, NITROGLYCERIN, PANTOPRAZOLE, FLUTICASONE PROPIONATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DULAGLUTIDE, ACETAMINOPHEN, ERGOCALCIFEROL, |
||||
26 | 25141445 |
CA |
47 | 2 |
Illness, Therapy interrupted, |
||||
CERTOLIZUMAB PEGOL, |
||||
27 | 25141481 |
US |
2 | |
Illness, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
28 | 25141537 |
US |
21 | 2 |
Illness, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
29 | 25141538 |
US |
74 | 2 |
Illness, |
||||
DUPILUMAB, DUPILUMAB, |
||||
30 | 25141571 |
US |
71 | 1 |
Illness, Influenza, Pain, Arthralgia, Joint warmth, |
||||
DUPILUMAB, |
||||
31 | 25141726 |
US |
2 | |
Illness, Product dose omission issue, Product storage error, |
||||
BELIMUMAB, |
||||
32 | 25142173 |
US |
73 | 1 |
Death, Illness, Product dose omission issue, |
||||
VELAGLUCERASE ALFA, VELAGLUCERASE ALFA, |
||||
33 | 25142180 |
US |
56 | 1 |
Illness, |
||||
TOFACITINIB, PREDNISONE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, NAPROXEN SODIUM, NAPROXEN SODIUM TABLET, |
||||
34 | 25142247 |
US |
25 | 2 |
Urinary tract infection, Illness, |
||||
TOFACITINIB, |
||||
35 | 25142608 |
US |
2 | 2 |
Illness, Device use error, Device material issue, Device leakage, |
||||
SOMATROPIN, |
||||
36 | 25142613 |
GB |
34 | 2 |
Haematemesis, Illness, Apathy, Muscle spasms, Fatigue, Malaise, |
||||
TIRZEPATIDE, |
||||
37 | 25142721 |
US |
||
Bronchitis, Illness, |
||||
ELOSULFASE ALFA, |
||||
38 | 25142765 |
US |
71 | 2 |
Rectal prolapse, Illness, Insomnia, Constipation, Incorrect dose administered, |
||||
LINACLOTIDE, LINACLOTIDE, DEXLANSOPRAZOLE, |
||||
39 | 25142797 |
US |
||
Hyperthyroidism, Constipation, Myalgia, Illness, |
||||
ROSUVASTATIN, |
||||
40 | 25142878 |
US |
2 | |
Anxiety, Decreased appetite, Back pain, Paraesthesia, Blood pressure fluctuation, Retching, Illness, Product lot number issue, Product substitution issue, Tremor, Therapeutic response decreased, Fatigue, Mental impairment, |
||||
LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
41 | 25145231 |
67 | 2 | |
Illness, Therapy interrupted, |
||||
UPADACITINIB, |
||||
42 | 25145245 |
67 | 2 | |
Illness, |
||||
ADALIMUMAB, |
||||
43 | 25145246 |
60 | 2 | |
Illness, |
||||
ETANERCEPT, |
||||
44 | 25145273 |
79 | 2 | |
Illness, |
||||
ADALIMUMAB, |
||||
45 | 25138248 |
US |
||
Illness, Cough, Device delivery system issue, Product packaging quantity issue, |
||||
ALBUTEROL SULFATE, |
||||
46 | 25138326 |
US |
35 | 1 |
Streptococcal infection, Illness, Impaired quality of life, |
||||
DUPILUMAB, |
||||
47 | 25138357 |
US |
77 | 2 |
Illness, |
||||
DUPILUMAB, |
||||
48 | 25141298 |
65 | 1 | |
Illness, Vomiting, Anxiety, Panic attack, Tremor, Loss of personal independence in daily activities, |
||||
TIRZEPATIDE, TIRZEPATIDE, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, LORAZEPAM, MAGNESIUM, |
||||
49 | 25137377 |
US |
||
Road traffic accident, Dyspepsia, Mental disorder, Illness, Benzodiazepine drug level abnormal, Product quality issue, Product substitution issue, Product tampering, |
||||
ALPRAZOLAM, CLONAZEPAM, ALPRAZOLAM, |
||||
50 | 25137379 |
US |
2 | |
Illness, |
||||
IBRUTINIB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, PREDNISONE, RIVAROXABAN, POLYETHYLENE GLYCOL 3350, ROSUVASTATIN, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, POTASSIUM CHLORIDE, ESCITALOPRAM OXALATE, ESCITALOPRAM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, |
||||
51 | 25137422 |
GB |
66 | 1 |
Illness, |
||||
PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
52 | 25137753 |
US |
2 | |
Illness, |
||||
IBRUTINIB, IBRUTINIB, IBRUTINIB, |
||||
53 | 25137761 |
US |
2 | |
Illness, Skin plaque, Drug ineffective, |
||||
RISANKIZUMAB-RZAA, |
||||
54 | 25137833 |
GB |
||
Hospitalisation, Illness, Intentional dose omission, |
||||
ADALIMUMAB, |
||||
55 | 25137889 |
US |
38 | 2 |
Illness, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
56 | 25137994 |
US |
||
Illness, Influenza, |
||||
EXENATIDE, |
||||
57 | 25140573 |
64 | 2 | |
Illness, |
||||
ADALIMUMAB, |
||||
58 | 25140920 |
57 | 2 | |
Illness, Therapy interrupted, |
||||
TOFACITINIB, |
||||
59 | 25132183 |
US |
24 | 1 |
Illness, Weight increased, |
||||
60 | 25132318 |
US |
80 | 2 |
Illness, Drug intolerance, |
||||
ENASIDENIB MESYLATE, |
||||
61 | 25132322 |
US |
55 | 2 |
Illness, |
||||
CLADRIBINE, |
||||
62 | 25132375 |
US |
1 | |
Hospitalisation, Renal injury, Stress, Anxiety, Cardiac disorder, Depression, Mental disorder, Delusion, Illness, Nervousness, |
||||
PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, |
||||
63 | 25132380 |
US |
54 | 1 |
Illness, |
||||
DARATUMUMAB AND HYALURONIDASE-FIHJ (HUMAN RECOMBINANT), |
||||
64 | 25132419 |
US |
51 | 2 |
Illness, |
||||
GALCANEZUMAB-GNLM, |
||||
65 | 25132498 |
US |
4 | 2 |
Illness, Injection site bruising, |
||||
DUPILUMAB, |
||||
66 | 25132499 |
US |
||
Immune system disorder, Bronchitis, Illness, |
||||
OCRELIZUMAB, |
||||
67 | 25132530 |
CA |
66 | 2 |
Pneumonia, Illness, Nasopharyngitis, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, METHOTREXATE SODIUM, CYCLOSPORINE, FOLIC ACID, |
||||
68 | 25132840 |
US |
2 | |
Rash, Condition aggravated, Off label use, Haemophagocytic lymphohistiocytosis, Illness, |
||||
ANAKINRA, ANAKINRA, |
||||
69 | 25133070 |
US |
2 | |
Dyspnoea, Fluid retention, Loss of consciousness, Illness, Cough, Fatigue, Headache, Constipation, |
||||
TREPROSTINIL, TREPROSTINIL, NINTEDANIB, NINTEDANIB, NINTEDANIB, NINTEDANIB, NINTEDANIB, |
||||
70 | 25133162 |
US |
2 | |
Illness, Disorientation, Head discomfort, Impaired driving ability, Fluid retention, Headache, |
||||
ESTRADIOL, ESTRADIOL, ESTRADIOL, |
||||
71 | 25133172 |
US |
2 | |
Illness, Pain, |
||||
ESTRADIOL, |
||||
72 | 25133297 |
US |
56 | 2 |
Mood swings, Myalgia, Panic disorder, Illness, Insomnia, Hot flush, Night sweats, Anxiety, Arthralgia, Incorrect dose administered by product, Product adhesion issue, |
||||
ESTRADIOL, TESTOSTERONE, TESTOSTERONE,, PROGESTERONE, |
||||
73 | 25133398 |
US |
1 | |
Illness, |
||||
DUPILUMAB, |
||||
74 | 25133475 |
US |
67 | 2 |
Illness, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
75 | 25133590 |
US |
||
Illness, Device delivery system issue, |
||||
LEVALBUTEROL TARTRATE, LEVALBUTEROL TARTRATE, |
||||
76 | 25133668 |
78 | 2 | |
Illness, Decreased activity, Abdominal discomfort, Nausea, |
||||
SOLRIAMFETOL, SOLRIAMFETOL, SEMAGLUTIDE, |
||||
77 | 25133675 |
60 | 2 | |
Illness, |
||||
SOLRIAMFETOL, |
||||
78 | 25133698 |
42 | 2 | |
Sleep disorder, Nasopharyngitis, Night sweats, Bowel movement irregularity, Illness, Fatigue, Nocturia, Unevaluable event, Cough, Terminal insomnia, Middle insomnia, |
||||
SOLRIAMFETOL, SODIUM OXYBATE, SODIUM OXYBATE, VIBEGRON, FEXOFENADINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE ORAL, FEXOFENADINE HCL, NAPROXEN SODIUM, NAPROXEN SODIUM TABLET, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, TRANEXAMIC ACID, FLUTICASONE PROPIONATE, MAGNESIUM, AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE, AZELASTINE HYDROCHLORIDE, FLUTICASONE PROPIONATE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, |
||||
79 | 25133862 |
US |
||
Illness, |
||||
TIRZEPATIDE, |
||||
80 | 25134013 |
US |
51 | 2 |
Illness, |
||||
DUPILUMAB, ALBUTEROL SULFATE, FEXOFENADINE HYDROCHLORIDE, LEVOTHYROXINE, MOMETASONE FUROATE AND FORMOTEROL FUMARATE DIHYDRATE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, |
||||
81 | 25134111 |
US |
1 | |
Viral load increased, Illness, |
||||
CABOTEGRAVIR AND RILPIVIRINE, CABOTEGRAVIR AND RILPIVIRINE, CABOTEGRAVIR AND RILPIVIRINE, BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE, |
||||
82 | 25134131 |
US |
||
Illness, |
||||
VIBEGRON, |
||||
83 | 25134332 |
GB |
68 | 1 |
Illness, |
||||
DULOXETINE HYDROCHLORIDE, DULOXETINE, SENNOSIDES, SENNA LEAF, SENNA, SENNOSIDES 8.6 MG TABLETS, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, CARBOPLATIN, LANSOPRAZOLE, AMLODIPINE, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, LOSARTAN, UMECLIDINIUM, ALBUTEROL SULFATE, ALBUTEROL, |
||||
84 | 25134677 |
US |
74 | 1 |
Illness, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
85 | 25134747 |
GB |
66 | 1 |
Illness, |
||||
PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
86 | 25134799 |
US |
71 | 1 |
Illness, |
||||
TELOTRISTAT ETHYL, |
||||
87 | 25134873 |
US |
2 | |
Illness, |
||||
88 | 25134983 |
US |
2 | |
Dyspnoea at rest, Productive cough, Headache, Hiccups, Throat irritation, Diarrhoea, Cough, Oropharyngeal pain, Fatigue, Poor quality sleep, Illness, Asthenia, Peripheral swelling, Dizziness, Vomiting, Nausea, Product deposit, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, NINTEDANIB, NINTEDANIB, NINTEDANIB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, |
||||
89 | 25134999 |
US |
64 | 2 |
Illness, Cough, Dyspnoea, |
||||
TOFACITINIB, |
||||
90 | 25135143 |
US |
66 | |
Illness, Product use issue, |
||||
POMALIDOMIDE, |
||||
91 | 25135234 |
CA |
68 | 2 |
Condition aggravated, Contusion, Grip strength decreased, Joint swelling, Osteoarthritis, Rheumatoid arthritis, Spinal stenosis, Tenderness, Treatment failure, Fall, Fatigue, Illness, Malaise, Pain, |
||||
DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, FOLIC ACID, LISINOPRIL, LISINOPRIL, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, LEVOTHYROXINE SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, METHYLPREDNISOLONE ACETATE, GOLD, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, |
||||
92 | 25135460 |
US |
||
Illness, |
||||
RAVULIZUMAB, |
||||
93 | 25135514 |
US |
||
Illness, Product use issue, |
||||
OLAPARIB, |
||||
94 | 25135557 |
US |
31 | 2 |
Malaise, Illness, Device issue, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
95 | 25135917 |
US |
42 | 1 |
Dysentery, Ill-defined disorder, Post-acute COVID-19 syndrome, Blood testosterone decreased, Illness, Depressed mood, Fatigue, Asthenia, Insomnia, Decreased appetite, Brain fog, Impaired work ability, Product dose omission issue, Product availability issue, Inappropriate schedule of product administration, |
||||
CHORIOGONADOTROPIN ALFA, |
||||
96 | 25136141 |
US |
||
Blood iron decreased, Full blood count decreased, Illness, |
||||
BUDESONIDE, |
||||
97 | 25136177 |
US |
6 | 2 |
Emergency care, Illness, Rash, Urticaria, |
||||
DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
98 | 25136480 |
US |
2 | |
Illness, Juvenile idiopathic arthritis, |
||||
ADALIMUMAB, |
||||
99 | 25136586 |
US |
||
Autoimmune thyroiditis, Illness, Rhinorrhoea, Cough, |
||||
ECULIZUMAB, |
||||
100 | 25136701 |
GB |
1 | |
Tooth abscess, Osteomyelitis, Psoriatic arthropathy, Decreased immune responsiveness, Illness, |
||||
SECUKINUMAB, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28